Ryman Healthcare Statistics

Total Valuation

NZE:RYM has a market cap or net worth of NZD 2.08 billion. The enterprise value is 3.77 billion.

Market Cap	2.08B
Enterprise Value	3.77B

Important Dates

The last earnings date was Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

NZE:RYM has 1.01 billion shares outstanding. The number of shares has increased by 3.28% in one year.

Current Share Class	1.01B
Shares Outstanding	1.01B
Shares Change (YoY)	+3.28%
Shares Change (QoQ)	+6.56%
Owned by Insiders (%)	3.34%
Owned by Institutions (%)	43.20%
Float	980.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	19.51
PS Ratio	2.74
PB Ratio	0.49
P/TBV Ratio	0.49
P/FCF Ratio	8.17
P/OCF Ratio	5.07
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.63
EV / Sales	4.97
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	14.81

Financial Position

The company has a current ratio of 0.04, with a Debt / Equity ratio of 0.40.

Current Ratio	0.04
Quick Ratio	0.01
Debt / Equity	0.40
Debt / EBITDA	n/a
Debt / FCF	6.72
Interest Coverage	-0.23

Financial Efficiency

Return on equity (ROE) is -10.91% and return on invested capital (ROIC) is -0.41%.

Return on Equity (ROE)	-10.91%
Return on Assets (ROA)	-0.21%
Return on Invested Capital (ROIC)	-0.41%
Return on Capital Employed (ROCE)	-0.66%
Revenue Per Employee	98,593
Profits Per Employee	-56,731
Employee Count	7,700
Asset Turnover	0.06
Inventory Turnover	626.17

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.68% in the last 52 weeks. The beta is 0.34, so NZE:RYM's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	-43.68%
50-Day Moving Average	2.45
200-Day Moving Average	3.91
Relative Strength Index (RSI)	25.32
Average Volume (20 Days)	2,640,834

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NZE:RYM had revenue of NZD 759.16 million and -436.83 million in losses. Loss per share was -0.62.

Revenue	759.16M
Gross Profit	8.07M
Operating Income	-40.39M
Pretax Income	-215.39M
Net Income	-436.83M
EBITDA	-5.40M
EBIT	-40.39M
Loss Per Share	-0.62

Full Income Statement

Balance Sheet

The company has 19.04 million in cash and 1.71 billion in debt, giving a net cash position of -1.69 billion or -1.67 per share.

Cash & Cash Equivalents	19.04M
Total Debt	1.71B
Net Cash	-1.69B
Net Cash Per Share	-1.67
Equity (Book Value)	4.26B
Book Value Per Share	4.20
Working Capital	-5.69B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 410.25 million and capital expenditures -155.59 million, giving a free cash flow of 254.66 million.

Operating Cash Flow	410.25M
Capital Expenditures	-155.59M
Free Cash Flow	254.66M
FCF Per Share	0.25

Full Cash Flow Statement

Margins

Gross margin is 1.06%, with operating and profit margins of -5.32% and -57.54%.

Gross Margin	1.06%
Operating Margin	-5.32%
Pretax Margin	-28.37%
Profit Margin	-57.54%
EBITDA Margin	-0.71%
EBIT Margin	-5.32%
FCF Margin	33.54%

Dividends & Yields

NZE:RYM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.28%
Shareholder Yield	n/a
Earnings Yield	-21.00%
FCF Yield	12.24%

Dividend Details

Stock Splits

The last stock split was on January 29, 2007. It was a forward split with a ratio of 5.

Last Split Date	Jan 29, 2007
Split Type	Forward
Split Ratio	5

Scores

NZE:RYM has an Altman Z-Score of -0.03. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.03
Piotroski F-Score	n/a